Gennex Laboratories Share Price
12 Nov, 2026 4:01 PM (IST)
Gennex Laboratories Performance
- Today's Low
- ₹9
- Today's High
- ₹9
- 52 Week Low
- ₹7
- 52 Week High
- ₹16
- Open Price₹9
- Previous Close₹9
- Volume447,721
- 50 DMA₹9.60
- 100 DMA₹10.00
- 200 DMA₹10.60
Gennex Laboratories Chart
Investment Returns
- Over 1 Month -4.37%
- Over 3 Month + 3.37%
- Over 6 Month -7.55%
- Over 1 Year -41.46%
Smart Investing Starts Here Start SIP with Gennex Laboratories for Steady Growth!
Gennex Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 9.4
- PEG Ratio
- 0.3
- Market Cap Cr
- 223
- P/B Ratio
- 1
- Average True Range
- 0.6
- EPS
- 1
- Dividend Yield
- 0
- MACD Signal
- -0.2
- RSI
- 47.1
- MFI
- 42.39
Latest Stock News Updates
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Saturday, November 14, 2026 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30, 2026 along with the Limited Review Report of the Statutory Auditors of the Company. Notice had been published in both Business Standard and Saksham (Local-Telugu) on November 04, 2026. We request you to take the above information on record and acknowledge receipt of the same.
- BSE India
- 6 days 3 hours ago
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. Consider and adopt the Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2026; 2. Consider the Limited Review Reports'' of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Half-Year ended September 30, 2026; 3. Other Business items.
- BSE India
- 1 week 2 days ago
With reference to the captioned subject matter, pursuant to regulation 74(5) of SEBI (DP) Regulations, 2018, we hereby submit the certificate received from the M/s R&D Infotech Private Limited, Registrar and Share Transfer Agent of the Company for the Quarter ended September 30, 2026. We request you to take the above information on record and acknowledge the receipt of the same.
- BSE India
- 4 weeks 2 days ago
Gennex Laboratories Financials
Gennex Laboratories Technicals
EMA & SMA
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹9.10
- 50 Day
- ₹9.60
- 100 Day
- ₹10.00
- 200 Day
- ₹10.60
Resistance and Support
- R3 9.60
- R2 9.40
- R1 9.20
- S1 8.90
- S2 8.70
- S3 8.50
Gennex Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-14 | Quarterly Results | |
| 2026-09-04 | A.G.M. | |
| 2026-08-14 | Quarterly Results | |
| 2026-05-30 | Audited Results | |
| 2026-04-16 | Others | Inter-alia, to consider 1. Decide regarding the conduct of EGM for Regularization of Additional Director Ms. Khushbu Kachhawa as a Director. 2. Appoint Scrutinizer for EGM. 3. Other business matters. |
About Gennex Laboratories
Gennex Laboratories is engaged in the business of manufacturing of Bulk Drugs and Intermediaries. View More- NSE Symbol
- GENNEX
- BSE Symbol
- 531739
- ISIN
- INE509C01026
Similar Stocks to Gennex Laboratories
Popular Stocks
Gennex Laboratories FAQs
Gennex Laboratories share price is ₹9 As on 12 November, 2026 | 17:13
The Market Cap of Gennex Laboratories is ₹223.3 Cr As on 12 November, 2026 | 17:13
The P/E ratio of Gennex Laboratories is 9.4 As on 12 November, 2026 | 17:13
The PB ratio of Gennex Laboratories is 1 As on 12 November, 2026 | 17:13
The 52 week High & Low of Gennex Laboratories is ₹16.2/₹7 respectively As on 12 November, 2026 | 17:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.